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1 article ''Technique for Intrapartum Administration of Surfactant without Requirement for an Endotracheal Tube'', and applaud the authors for their efforts in this feasibility study investigating early, easy techniques to reduce the incidence of neonatal respiratory distress syndrome (RDS). In the event, the authors or others wish to pursue investigation of the utility of this technique, we wish to raise certain issues that need to be addressed as part of investigating the feasibility of applying this technique in clinical practice.
Firstly, the authors do not discuss their rationale for using the same dose of InfaSurf surfactant as is used for intratracheal instillation. As it is highly unlikely that the infants studied aspirated the entire dose of surfactant administered, their results would underestimate the benefit of prophylactic administration of nasopharyngeal surfactant. One possible solution to this problem would be to use a greater volume of surfactant for nasopharyngeal administration than is used for intratracheal instillation for prophylaxis/treatment of RDS. Alternatively, one could use a concentrated surfactant solution for nasopharyngeal instillation as was used in the animal studies by Enhorning et al. 2, 3 A solution that allowed quantification of the amount of nasopharyngeally instilled surfactant that did make its way into the lungs would be ideal. This last goal may be achieved by combining the desired surfactant with a small volume of perfluorocarbons as is used for partial liquid ventilation. 4 This approach would have a dual advantage of allowing visualization of the radio-opaque perfluorocarbon on a postnatal chest radiograph, as well as have beneficial effects on lung function. As perfluorocarbons have been shown to improve oxygenation and lung compliance in neonates with surfactant-deficient lungs, 4, 5 it is possible that use of a concentrated solution of surfactant with perfluorocarbons might dramatically improve lung function, and decrease the numbers of preterm infants needing to be intubated. In the event, some small preterm infants are intubated for rescue surfactant therapy, a potential added benefit of using a perfluorocarbon-surfactant mixture might be a decreased incidence of bronchopulmonary dysplasia resulting from perfluorocarbon-mediated attenuation of pulmonary inflammatory response. 6, 7 Unquestionably, the benefits and risks of this innovative strategy need careful prospective evaluation. Secondly, of the 23 infants studied by Kattwinkel et al., 1 only two and three infants were less than 1000 g and less than 28 weeks gestation, respectively. As surfactant treatment for RDS is inversely related to gestational age, 8 smaller preterm infants most in need of prophylactic surfactant therapy were not studied. Hence, whether extremely low birth weight infants would be able to muster adequate respiratory effort to aspirate the exogenously administered surfactant or whether this type of therapeutic approach would be safe for smaller premature infants remains uncertain. In addition, while a benefit of this prophylactic approach was probably afforded to some of the study patients, others may not have benefited as surfactant therapy is only necessary for about 45 to 55% of infants at 28 to 29 weeks gestation compared to more than 80% of infants born at 24 to 26 weeks gestation (Vermont Oxford data). 8 Further studies designed to investigate the utility of prophylactic administration of nasopharyngeal surfactant in smaller preterm infants would help resolve these issues.
Lastly, although the technique described by the authors appears relatively easy, other pragmatic considerations remain. In the study described, 1 a neonatologist was present to assist the obstetrician and instill the surfactant into the infant's nasopharynx. As prophylactic surfactant treatment for infants at risk of RDS is more efficacious than selective treatment of established RDS 9, 10 and as neonatologists may not always be present at every preterm birth, the efficacy of using this technique to prevent RDS would necessarily depend on the combined efforts of both neonatologists and obstetricians in the delivery room.
